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Abstract
Background: Human adult adipose tissue is an abundant source of mesenchymal stem cells (MSCs). Moreover, it is an easily
accessible site producing a considerable amount of stem cells.
Methodology/Principal Findings: In this study, we have selected and characterized stem cells within the stromal vascular
fraction (SVF) of human adult adipose tissue with the aim of understanding their differentiation capabilities and
performance. We have found, within the SVF, different cell populations expressing MSC markers – including CD34, CD90,
CD29, CD44, CD105, and CD117 – and endothelial-progenitor-cell markers – including CD34, CD90, CD44, and CD54.
Interestingly, CD34
+/CD90
+ cells formed sphere clusters, when placed in non-adherent growth conditions. Moreover, they
showed a high proliferative capability, a telomerase activity that was significantly higher than that found in differentiated
cells, and contained a fraction of cells displaying the phenotype of a side population. When cultured in adipogenic medium,
CD34
+/CD90
+ quickly differentiated into adipocytes. In addition, they differentiated into endothelial cells (CD31
+/VEGF
+/Flk-
1
+) and, when placed in methylcellulose, were capable of forming capillary-like structures producing a high level of VEGF, as
substantiated with ELISA tests.
Conclusions/Significance: Our results demonstrate, for the first time, that CD34
+/CD90
+ cells of human adipose tissue are
capable of forming sphere clusters, when grown in free-floating conditions, and differentiate in endothelial cells that form
capillary-like structures in methylcellulose. These cells might be suitable for tissue reconstruction in regenerative medicine,
especially when patients need treatments for vascular disease.
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Introduction
Stem cells are undifferentiated cells that undergo multiple,
sequential cell divisions, that have the ability to renew themselves,
and that, in the adult, are responsible for repair and repopulating
damaged tissues [1]. Therefore, they are the natural and direct source
from which stable differentiated cells can form an adult tissue.
Moreover, they can differentiate into specialized cell types [2].
Mesenchymal stem cells of bone marrow (BM-MSCs) have been
studied for years [3,4]; these cells can differentiate into adipocytes,
osteoblasts [5] and other cells of mesenchymal origin [6,7] . Recently,
new sources of adult stem cells have been discovered in different
tissues of the human body, including dental pulp [8,9], Wharton Jelly
[10,11], amniotic membrane [12], and adipose tissue [13].
Adipose tissue represents an important source of adult stem
cells, called ASCs (adipose stem cells) [14,15]. ASCs share many
characteristics of bone marrow, including extensive proliferation
and the ability to undergo multilineage differentiation [16], and
they display a noticeable plasticity both in vitro [17] and in vivo [18].
In fact, ASCs can express the biochemical profile of adipocytes,
chondrocytes, and osteoblasts under appropriate culture condi-
tions in vitro [19,20]. In addition, the stromal vascular fraction
(SVF) of human adipose tissue has been recently reported to be
capable of differentiating into endothelial cells [21]; it has been
also demonstrated that these cells can enhance neovascularization
in a murine ischemic model [22] and secrete angiogenic growth
factors [23]. Moreover, a large number of stem cells can be
obtained from adipose tissue because it is abundant in the body
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6537and highly accessible; thus, ASCs are tremendous interest to
regenerative medicine [24].
The aim of this study was to characterize stem/progenitor cells
found within the SVF of adipose tissue and label their phenotypic
profile during the steps of isolation, purification, and expansion. In
particular, their kinetics were followed though the expression of
different markers for stem and differentiated cells. We have
focused our attention on progenitor cells showing both an
angiogenic and adipogenic potential.
Our study has shown the following results and novelties with
respect to the existing literature on this topic: (i) two different
populations can be detected within the SVF of human adipose
tissue: mesenchymal stem cells expressing CD90, CD29, CD44,
CD105, CD117, and CD34; and endothelial progenitor cells,
expressing CD34, CD90, CD44, and CD54; (ii) CD34
+/CD90
+
cells are capable of differentiating into endothelial cells (CD31
+/
VEGF
+/Flk-1
+) and, when stimulated with an adipogenic
medium, into adipocytes; (iii) these cells are also capable of
forming sphere clusters, when grown in free-floating conditions,
and capillary-like structures, when challenged on methylcellulose,
as substantiated by production of VEGF.
Results
Cell Culture
After enzymatic digestion of adipose tissue, samples of 1,000,000
cells were collected from the cell suspension and cultured. After
three days of culture, adherent cells acquired a fibroblast-like or
polygonal shape morphology. This morphology was maintained
through several passages under standard culture conditions from
cells belonging to both mammary and abdominal regions.
Flow cytometry assay
At day 0, antigenic analysis of cells belonging to both mammary
and abdominal regions showed that different cell types were
detectable within the SVF; these were positive for CD29 (b1-
integrin) (89%), CD34 (sialomucin and L-selectin ligand) (33%),
CD90 (Thy-1) (52%), CD117 (10%), CD105 (endoglin) (12%), and
CD133 (4%); and for differentiated cell-associated markers such as
CD31 (9%), CD44 (5%) CD54 (9%), and Flk-1 (VEGFR-2) (32%).
At day 15, the number of CD34
+ and CD90
+ cells belonging to
both mammary and abdominal regions increased consistently up
to 80%. After 30 days of culture, CD34 decreased significantly
down to 8%, while CD90 expression held steady at 80% (Fig. 1).
At this time, sorted CD34
+/CD90
+ cells acquired an endothelial
morphology and expressed high levels of endothelial markers such
as CD90 (97%), CD44 (90%), CD54 (90%), VEGF (70%) , CD133
(18%), and Flk-1 (60%) (Fig. 2). All cells tested were negative for
CD14 (monocyte marker) and CD45 (leucocyte marker). The
absence of these markers distinguished the different cell popula-
tions from cells of hematopoietic lineage.
Proliferation Assay
Hoechst 33342 analysis performed both on CD34
2 and CD34
+
cells showed that CD34
2 cells were mostly in G0/G1 phase with
respect to CD34
+ cells (Fig. 3A,C). Ki-67 is a nuclear protein
expressed only in proliferating cells, and cell cycle events can be
detected following Ki-67 expression: in fact, cells in late G1 phase,
S phase, and G2/M phase are Ki-67
+.
We found that all CD34
+/CD90
+ cells resulted to be Ki-67
+,
whereas the majority of CD34
2/CD90
2 cells were negative for
this marker (Fig. 3 B,D). Thus, our results confirm that the
CD34
+/CD90
+ fraction is the source of stem cells. Moreover,
CD34
+/CD90
+ cells exhibited a high proliferative capacity in
culture; in fact, after 7 days, the proliferation rate was higher
(85%) than that of CD34
2/CD90
2 cells (10%).
Side population analysis
After enzymatic digestion, the SVF cells of adipose tissue were
labeled with Hoechst 33342 to detect the side population (SP). We
found that the SVF contains only a small number of cells with SP
characteristics (2% of the total population). These cells were all
positive for CD34 (Fig. 4).
Sphere Cluster Formation
Cultured CD34
+/CD90
+ cells formed spheres already after
24 h whereas CD34
2/CD90
2 did not (Fig. 5A). After 7 days of
culture, CD34
+/CD90
+ cell-spheres were seeded into standard
medium with 10% FBS. Cells migrated from the spheres within a
few hours and adhered to the bottom of the flasks, where they
assumed a fibroblast-like shape. Moreover, in order to investigate
whether the spheres maintained or increased CD34 expression, we
performed analysis for CD34 and CD90 at passage 5. We have
found that the spheres become enriched in CD34 (95–98%) with
low levels of CD90 (2–3%) (Fig. 5C). These results were observed
both in CD34
+/CD90
+sorted cells and in non-sorted cells.
Telomerase activity
The majority of researchers report that differentiation down-
regulates telomerase activity both in stem cells and in cancer cell
lines. It is also known that telomere shortening occurs during
replicative ageing, possibly at a slower rate than in normal somatic
cells. Therefore, to establish whether stem cells were induced to
differentiate and to undergo replicative senescence, we evaluated
telomerase expression. In our hands, at 30 days of culture,
telomerase activity of differentiated endothelial cells (DA=0.160)
was significantly reduced (p,0.001) with respect to undifferenti-
ated CD34
+/CD90
+ cells (DA=0.377) (Fig. 5B).
In vitro adipogenic differentiation
The effect of adipogenic conditions on the cell subtypes of the
SVF was studied. Both sorted (CD34
+/CD90
+ as well as CD34
2/
CD90
2) and non-sorted cells were placed in adipogenic medium
for three weeks. Under this condition, CD34
+/CD90
+ cells
acquired the typical morphology of lipid-laden cells containing
intracellular lipid droplets (Fig. 6A,B), that were positive at
immunoistochemistry for adiponectin already after 24 h
(Fig. 6C,D). On the contrary, CD34
2/CD90
2 cells were not
able to differentiate into adipocytes and they did not express
adipogenic markers (Fig. 6E,F).
In vitro angiogenic differentiation
The effect of angiogenic conditions was also studied. At 48 h/
72 h, CD34
+/CD90
+ cells cultured on methylcellulose either with
or without VEGF started to form a vascular network (Fig. 7A).
After day 7, these cells formed an extensive intercellular tube
network including small and large round cells and large flat cells
with endothelial morphology that formed clusters (Fig. 7B); most
were strongly positive for endothelial markers, including CD90
(Fig. 7C), VEGF (Fig. 7D), CD31 (Fig. 7E), but negative for CD34.
The positivity for VEGF antigens was also confirmed by
immunohistochemical staining (Fig. 7F).
ELISA analysis for VEGF
In order to substantiate CD34
+/CD90
+ ASCs endothelial
differentiation, we analyzed the quantity of VEGF produced by
these sorted cells in the culture period at different time points.
CD34
+/CD90
+ ASCs Cells
PLoS ONE | www.plosone.org 2 August 2009 | Volume 4 | Issue 8 | e6537Figure 1. Representative flow cytometry analysis performed at day 0, 15, and 30 of culture. A significant number of ASCs at day 0 are
clearly positive for mesenchymal markers, including CD29 (89%), CD105 (12%), CD34 (33%), CD90 (52%), CD117 (10%), and for endothelial markers,
including CD31 (9%), CD133 (4%), CD44 (5%), CD54 (9%), and Flk-1 (32%). At day 15 the CD34 and CD90 levels consistently increased (80%). After 30
days of culture, CD34 levels significantly decreased down to 8%, while the CD90 expression held steady at 80%. Later, cells were mainly positive for
CD44 and CD54 antigens (87%). Control PE-conjugated and FITC-conjugated isotypes were negative and all cells were negative for CD45 antigens.
doi:10.1371/journal.pone.0006537.g001
CD34
+/CD90
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+/CD90
+ ASCs secreted high VEGF
levels, which increased with time. In fact, at 140 hours, VEGF
quantity was found to be of 5130 pg/ml with respect to the value
of 336 pg/ml found at 12 hours, demonstrating a 15-fold
increased level (Fig. 7G) with p,0.05. Moreover, at day 12,
VEGF was 6331 pg/ml of medium with respect to 382 pg/ml
found at day 1, showing a 16-fold increase (Fig. 7H) with p,0.05.
RT-PCR analysis
Expression of CD34, CD90, CD44, CD54, VEGF, and Flk-1
mRNA levels, confirmed the results obtained with flow cytometry
and immunofluorescence analyses (Fig. 8A).
RT-PCR analyses were performed at 7 and 30 days after sorting
on CD34
+/CD90
+ cells. The increased lipid storage within the
CD34
+/CD90
+ cells grown under adipogenic condition was
characterized by the presence of transcriptional regulators of
adipogenesis: the expression of early and late markers of the
adipocyte differentiation process was observed, with PPARc and
adiponectin at 7 and 30 days. (Fig. 8B,C).
Discussion
In this study, we have isolated and characterized stem/progenitor
cells from human adult adipose tissue withdrawn from mammary (via
Figure 2. Representative flow cytometry analysis performed on CD34
+/CD90
+ cells at day 30 from sorting. A significant number of ASCs
are clearly positive for endothelial markers, including CD90 (97%), CD44 (90%), CD54 (90%), VEGF (70%), CD133 (18%), and Flk-1 (60%). Control PE-
conjugated and FITC-conjugated isotypes were negative.
doi:10.1371/journal.pone.0006537.g002
CD34
+/CD90
+ ASCs Cells
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We did not observe significant differences between the two sites of
withdrawal. Our attention was focused on the stromal vascular
fraction (SVF) of adipose tissue. In freshly isolated SVF cells,
fluorescence activated cell sorting analyses evidenced the presence of
two cell subpopulations: a CD34
+/CD90
+/CD29
+/CD44
+/
CD105
+/CD14
2/CD45
2 mesenchymal stem/progenitor cell pop-
ulation; and a CD44
+/CD54
+/VEGF
+/Flk-1
+ endothelial cell
population. We decided to study the cell subset co-expressing
CD34 and CD90 antigens, and evaluated surface marker expression
at 0, 15, and 30 days from fresh tissue samples – this because the
CD34 marker is an antigen identified on the surface of hematopoietic
stem cells, but it is well expressed also on stromal stem cells,
fibroblasts, hematopoietic progenitors [25], and endothelial progen-
itors [26]. Analysis of CD34 with other markers such as CD14 and
CD45 (hematopoietic progenitors); CD90, CD117, and CD105
(mesenchymal stem cells); and CD31 and CD133 (endothelial
progenitors) is an useful tool for stem-progenitor cell characterization.
CD90, on the other hand, is generally expressed on thymocytes,
neurons, mesenchymal stem cells, hematopoietic stem cells, NK cells,
endothelium (mainly in high endothelial venules (HEVs), where
diapedesis takes place, renal glomerular mesangial cells, circulating
metastatic melanoma cells, follicular dendritic cells (FDC), a fraction
of fibroblasts, and myofibroblasts.
Our study has revealed a significant expression of both CD34
and CD90 markers in cells freshly isolated from the adipose SVF.
Figure 3. Cell cycle analysis performed using Hoechst 33342 and Ki67 both on CD34 negative and positive cells. (A) Hoechst 33342
analysis performed CD34
2 cells: G0G1 phase (98%), S phase (0,65%) and G2M phase (0,50%); (B) Ki67 analysis performed CD34- cells: Ki67 (10%); (C)
Hoechst 33342 analysis performed CD34
+ cells: G0G1 phase (84%), S phase (5%) and G2M phase (10%); (D) Ki67 analysis performed CD34+ cells: Ki67
(85%).
doi:10.1371/journal.pone.0006537.g003
CD34
+/CD90
+ ASCs Cells
PLoS ONE | www.plosone.org 5 August 2009 | Volume 4 | Issue 8 | e6537The absence of CD14 and CD45 distinguished this cell subset
from cells of hematopoietic lineage. During cultures, the CD34
antigen underwent down-regulation, whereas CD90 expression
held steady while cells acquired the following antigens: VEGF
+,
CD44
+, CD54
+, and Flk-1
+, confirming the endothelial differen-
tiation.
The novelty of this study lives in the demonstration that, in the
SVF, there is a CD34
+/CD90
+ stem cell population capable of
differentiating into endothelial cells and forming capillary-like
structures in a semisolid medium with or without the use of
angiogenic factors. In fact, during the first 12 h of culture, we
have found that the non-adherent cells, grown in methylcellu-
lose, with or without the addition of VEGF, formed small-sized,
large-sized round cells with cytoplasmic granules and larger flat
cells with an endothelial morphology. After 24 h, cell clusters
increased in size and formed connections among them, whereas
after 48 h/72 h, cells with an endothelial morphology, formed
an extended intercellular tubular network. On the other hand,
this population, when isolated at day 0 by flow cytometry, gave
rise to multivacuolar adipocytes, if cultured in adipogenic
medium. In addition, these cells are capable of forming sphere
clusters in a serum-free medium supplemented with bFGF and
EGF. Interestingly, during the time of floating culture, spheres
maintained the expression of the CD34 antigen, whereas CD90
levels became down-regulated. This was observable either in the
case of the CD34/CD90 sorted cell population or in non-sorted
cells.
The finding that floating cell cultures maintain and even increase
the stemness potential of stem/progenitor-derived cells, probably
inhibiting differentiation patterns, must be regarded as another
significant result of this study. Consequently, this technique may be
used to maintain stem characteristics for a longer time with respect
to traditional adhesion cultures. In fact, our CD34
+/CD90
+ stem
cells differentiated in to endothelial cells after 30 days from cell
sorting in adhesion cultures, whereas they maintained their
stemness up to 60 days, when cultured as floating sphere clusters.
Telomerase activity of differentiated cells was also significantly
reduced with respect to the parental CD34
+/CD90
+ cell subset.
Telomeres are specific structures found at the end of chromosomes
in eukaryotes. In human chromosomes, telomeres consist of
thousands of copies of 6 base repeats (TTAGGG). It has been
suggested that telomeres protect chromosome ending, because
damaged chromosomes lacking telomeres undergo fusion, rear-
rangement, and translocation. In somatic cells, telomere length is
progressively shortened after each cell division both in vivo and in
vitro, due to the inability of the DNA polymerase complex to
synthesize the 59 end of the lagging strand.
Moreover, CD34
+CD90
+ cells had a high proliferative poten-
tial, and a small fraction of CD34
+ cells (2%) expressed the
characteristic profile of a side population. It is known that the side-
population phenotype is the most significant attribute of stem cells.
This study is the first to report the presence of a side population in
the SVF of adipose tissue. We hypothesize that this side population
is formed of primitive stem cells.
Figure 4. Side population assay. Image of the CD34
+ fraction representing a very small subset (2%), expressing the characteristic side-population
profile.
doi:10.1371/journal.pone.0006537.g004
CD34
+/CD90
+ ASCs Cells
PLoS ONE | www.plosone.org 6 August 2009 | Volume 4 | Issue 8 | e6537Figure 5. Spheres formation, cytometric analysis and telomerase activity. (A) Sphere clusters formed by CD34
+/CD90
+ cells in semisolid
medium after 24 hours (Original Magnification6100); (B) Cytometric analysis on adherent cells for CD90 (80%) and CD34 (80%) antigens and on
floating spheres for CD90 (2–3%) and CD34 (95–98%) antigens; (C) Telomerase activity of differentiated endothelial cells (DA=0.160) was significantly
reduced (p,0.001) respect to undifferentiated CD34
+/CD90
+ cells (DA=0.377)
doi:10.1371/journal.pone.0006537.g005
CD34
+/CD90
+ ASCs Cells
PLoS ONE | www.plosone.org 7 August 2009 | Volume 4 | Issue 8 | e6537Figure 6. Adipogenic differentiation. (A) ASCs in DMEM 10% FBS exhibit a fibroblast-like morphology (Original magnification 1006); (B) ASCs in
adipogenic medium exhibit an adipocyte morphology (Original magnification 1006); (C) CD34
+/CD90
+ cells in DMEM 10% FBS showing negativity for
adiponectin by immunohistochemistry (Original magnification 4006); (D) CD34
+/CD90
+ cells in adipogenic medium showing positivity for
adiponectin by immunohistochemistry (Original magnification 1006); (E) CD34
2/CD90
2 cells in DMEM 10% FBS showing negativity for adiponectin
by immunohistochemistry (Original magnification 1006); (F) CD34
2/CD90
2 cells in adipogenic medium showing negativity for adiponectin by
immunohistochemistry (Original magnification 4006).
doi:10.1371/journal.pone.0006537.g006
CD34
+/CD90
+ ASCs Cells
PLoS ONE | www.plosone.org 8 August 2009 | Volume 4 | Issue 8 | e6537Figure 7. Endothelial differentiation. (A) Image showing differentiated endothelial cells that, after 48 h in methylcellulose, acquire a different
morphology comprising round cells with cytoplasmic granules and large flat cells with endothelial morphology (Original magnification 4006); (B)
Image showing differentiated endothelial cells that, after day 7 in methylcellulose, formed an extensive intercellular tube networks (Original
magnification 4006); Immunofluorescence images of differentiated endothelial cells showing positivity for several specific markers including (C)
CD90 (Original magnification 1006); (D) VEGF (Original magnification 1006); (E) CD31 (Original magnification 1006); (F) Immunohistochemistry
images of differentiated endothelial cells showing positivity for VEGF (Original magnification 1006); (G) At 140 hours, VEGF quantity was found to be
of 5130 pg/ml with respect to the value of 336 pg/ml found at 12 hours; (H) At day 12, VEGF was 6331 pg/ml of medium with respect to 382 pg/ml
found at day 1.
doi:10.1371/journal.pone.0006537.g007
CD34
+/CD90
+ ASCs Cells
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CD90 antigens identifies a cell population capable of forming
vessels. This might have an important impact on therapeutic
strategies for ischemic tissue damage of myocardium, retina, and
limbs [22,27] because these cells secrete angiogenic cytokines such
as IL-1b, which plays a crucial role in the angiogenic process [28].
Recent studies indicate that portions of ischemic and tumor
neovasculature are due to a ‘‘neovasculogenesis’’, whereby bone
marrow (BM)-derived circulating endothelial progenitor cells
(EPCs) home to sites of regenerative or malignant growth and
contribute to blood vessel formation. Therapeutic angiogenesis is
an important survival mechanism that preserves the integrity of
tissues subjected to ischemia [29,30].
Currently, autologous endothelial progenitor cells (EPCs) can be
isolated and expanded from adult human peripheral blood for
therapeutic angiogenesis [31] . However, the number of EPCs
obtained from peripheral blood is limited. At present, it is difficult
to use autologous cord blood-derived EPCs clinically, therefore,
other sources of EPCs should be explored.
In this study, we have demonstrated that our cells gradually lose
their positivity for CD34 and acquire an endothelial morphology,
expressing high levels of endothelial markers, including CD31,
CD44, CD54, Flk1, and VEGF. Moreover, as substantiated by the
ELISA assay, VEGF was produced at very high levels in the
standard medium during culture. Therefore, our CD34
+/CD90
+
cells seem to be different from those reported by Cao et al. [32]
which expressed Flk1, but not CD34. Moreover, a large amount of
studies indicate that VEGF is required and necessary to promote
endothelial differentiation starting from mesenchymal stem cells.
In this study, we have demonstrated that CD34
+/CD90
+ cells of
human adipose tissue differentiate in endothelial cells with
formation of capillary-like structures in methylcellulose due to
their own VEGF production. In addition, we have demonstrated
that it is possible to maintain stemness for a long time during cell
culture through sphere growth. These findings suggest that stem
cells isolated from SVF of human adipose tissue are involved in
angiogenesis in order to repair vascular damage and in forming
new blood vessels. Moreover, as previously demonstrated by us
[24], vessel formation from ASCs is of high interest because this is
involved in the genesis of a tissue in vitro.
In conclusion, this study has shown the following: (i) within
human adipose tissue of subjects of 18 to 45 years of age, a rather
consistent number of CD34
+/CD90
+/CD45
2 stem cells can be
selected; (ii) these cells can be considered mesenchymal stem cells
and are able to differentiate into the same different lineages
characteristic ofMSCs: infact,both stromal and mesenchymalstem
cells become progressively CD34
2 while differentiating and this
excludes contamination from marrow fibroblasts; (iii) in culture,
these cells proliferate and differentiate on methylcellulose into
endotheliocytes due to their high production levels of VEGF, and,
under specific stimuli, into multivacuolar adipocytes, as confirmed
by RT-PCR for adiponectin and PPAR-c. The strong PPARc
expression suggests that this gene has a predominant roleduring cell
differentiation; (iv) in free floating cultures, these cells are capable of
forming sphere clusters, which can preserve cell stemness for a long
period; and (v) they have high telomerase activity, leading to a long
lifespan. Moreover, ASCs can be frozen in liquid nitrogen for at
least one year without loss of their stemness [33].
Thus, stem cells isolated from the SVF of human adult adipose
tissue are an easily accessible, potentially abundant source of cells
suitable for clinical applications in vascular regenerative medicine
and in soft tissue engineering.
Figure 8. RT-PCR analysis. (A) Representative figure of RT-PCR showing mRNA transcript expression of CD90, CD34, CD44, CD54, VEGF, Flk-1, on
cells in DMEM 10% FBS 7, 15 and 30 days of culture; (B) PPARc and adiponectin on cells in adipogenic medium at 7 and (C) 30 days of culture.
doi:10.1371/journal.pone.0006537.g008
CD34
+/CD90
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Adipose tissue harvesting and digestion
Subcutaneous adipose tissue from abdomen and mammary was
obtained following written informed consent, approved by our
Internal Ethical Committee (Second University Ethical Commit-
tee) from 54 female patients with a mean age of 3560,8 years and
with a mean BMI of 2661.1 Kg/m
2 that had endured elective
procedures for plastic surgery. Adipose tissue was obtained by
lipectomy or liposuction in the Plastic and Reconstructive Surgery
Clinic of the Second University of Naples. The adipose tissue was
placed in a physiological solution (0.9% NaCl), washed twice in
PBS (phosphate saline buffer: 137 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4, 1.8 mM KH2PO4), scraped, and placed in a
digestion solution: collagenase type I (3 mg/ml) and dispase
(4 mg/ml) supplemented with penicillin (100 U/ml), streptomycin
(100 mg/ml), and clarythromicin (500 mg/ml) in PBS at 37uCi n
agitation for 60 min. The digest was filtered through 70 mm filters
(Becton & Dickinson, Sunnyvale, CA).
Cell culture
After filtration and washing, the pellet was resuspended in
erythrocyte lysis buffer (155 mM NH4Cl, 10 mM KHCO3,
0.1 mM EDTA, pH 7.3) for 10 min at room temperature. The
cell suspension was centrifuged at 1300 rpm for 7 min and the
pellet resuspended in 5 ml Dulbecco’s modified Eagle’s medium
(DMEM) with 10% fetal bovine serum (FBS), 2 mM L-glutamine,
100 U/ml penicillin, and 100 mg/ml streptomycin and seeded in
25 cm
2 flasks. Flasks were incubated at 37uC under 5% CO2 and
the medium changed twice a week. Cells reached confluence in 5–
7 days. Experiments were performed in quadruplicate.
Flow cytometry
Cells were detached using trypsin-EDTA (200 mg/L EDTA,
500 mg/L trypsin; Cambrex). At least 200,000 cells were
incubated with primary antibody for 30 min at 4uC, washed
twice in PBS, and incubated with a secondary antibody.
Alternatively, cells were incubated directly with fluorescent-
conjugated antibodies for 30 min at 4uC, washed, and resus-
pended in 0.6 ml PBS. Samples were analyzed at day 0 (day of
surgery), day 15, and day 30 by flow cytometry using a FACS
Vantage cell sorter (Becton & Dickinson, Mountain View,
CA,USA). The antibodies used in this study were: anti-CD117
PE (c-kit) (Miltenyi–Biotech, Calderara di Reno, Bologna, Italy);
anti-CD34 FITC and PE (Miltenyi-Biotech); anti-CD90 FITC
(BD Pharmingen, Buccinasco, Milano, Italy); anti-CD105 FITC
(Santa Cruz, CA, USA); anti-CD29 Cy (Miltenyi-Biotech); anti-
CD31 FITC (Miltenyi-Biotech); anti-CD133 PE (Miltenyi-Bio-
tech); anti-hVEGF (Santa Cruz, CA); anti-VEGFR-2 (Santa
Cruz); anti-CD54 PE (Miltenyi-Biotech); anti-CD44 FITC
(Miltenyi-Biotech), anti-CD45 Cy and PE (BD Pharmingen,
Buccinasco, Milano, Italy); and anti-CD14 PE (Miltenyi-Biotech).
For intracellular staining of Ki67 (Miltenyi-Biotech), CD34
+/
CD90
+ cells were processed using the Caltag Fix & Perm Kit
(Invitrogen, Milan, Italy) following the manufacturer’s guidelines.
All data were analyzed using CellQuest software (Becton &
Dickinson, Mountain View, CA,USA).
For DNA staining , cells were incubated for 90 min at 37uCi n
basal medium with Hoechst 33342 (5 mg/ml Sigma, Milan, Italy).
Data analysis was performed with ModFit 3.0 software.
Cell Sorting
At day 0, CD34
+/CD90
+ cells were sorted and cultured in order
to perform the following experiments: sphere assay, differentiation
assays, proliferation assay, side population assay, and telomerase
activity. This isolated CD34
+/CD90
+ population expresses neither
the leukocyte marker, CD45, nor the monocyte/macrophage
marker, CD14. Both sorted CD34
2/CD90
2 and non-sorted cells
were used as controls.
Side Population Analysis
After enzymatic digestion, aliquots of SVF cells were washed
with ice-cold PBS/2% FBS. Cells (500,000) were labeled in the
growth medium with 5.0 mg/ml Hoechst 33342 dye, either alone
or in combination with 50 mg/ml verapamil at 37uC for 90 min.
After washing with PBS/2% FBS, the cells were incubated with
2 mg/ml propidium iodide to exclude dead cells. The Hoechst dye
was excited with UV laser and its fluorescence measured with
675/20 (Hoechst Red) and 424/44 (Hoechst Blue) filters.
Limited dilution assay and proliferative potential
In order to assess clonogenic as well as proliferative ability of
cells, suspensions of stem cells (CD34
+/CD90
+/CD45
2) were
diluted and single cells seeded in 96 multiwells. Two weeks later,
cells were stained with Toluidine blue in order to assess their
proliferation rate.
Sphere cluster formation assay
Cells were plated at a density of 60,000 cells/well in 6-well ultra
low attachment plates (Corning Inc., Corning, NY, USA) in
DMEM/F12 cell medium supplemented with 1% methylcellulose,
progesterone (10 nM), putrescine (50 mM), sodium selenite
(15 nM), transferrin (13 mg/ml), insulin (10 mg/ml; Sigma, Milan,
Italy), human EGF (20 ng/ml), and human bFGF (20 ng/ml;
Sigma). Fresh aliquots of EGF and bFGF were added every other
day. After culture for 48–72 hours, spheres were visible at the
inverted phase-contrast microscope (Nikon TS 100, Nikon,
Florence, Italy). Moreover, in order to investigate if the spheres
may maintain or enrich CD34 expression during suspension
culture, we performed CD34 and CD90 analysis at passage 5,
starting both from cells sorted for CD34/CD90 and the total cell
population. The spheres were detached using trypsin-EDTA
(200 mg/L EDTA, 500 mg/L trypsin; Cambrex) and analyzed for
CD34PE (Miltenyi-Biotech) and CD90 FITC (BD Pharmingen) by
flow cytometry.
Telomerase activity
The TRAPeze ELISA Telomerase Detection Kit was used to
perform the telomeric repeat amplification protocol (TRAP) and
ELISA assayforthe non-quantitative detection oftelomeraseactivity
in treated cells versus control, according to manufacturer’s
instructions (Chemicon International, Milan, Italy). Briefly, the kit
is based on two main steps: TRAP extension/amplification and
detection. The TRAP extension/amplification reaction is performed
with biotinylated primer and a deoxynucleotide mix containing
dCTP labeled with dinitrophenyl (DNP). The labeled products are
then detected by anti-DNP antibody conjugated to horseradish
peroxidase (HRP). The amount is determined by the HRP activity
using the substrate, 3,39,5,59-tetramethylbenzidine, and subsequent
color development. Exponentially growing cells were seeded into
75 cm
3 flasks at 2610
5 cells/mL in triplicate. Differentiation was
induced up to day 21. Total proteins of cell extracts were quantified
using the BioRad assay. The positive control was provided by the
supplier of the kit. For the negative control, extracts from cells were
heated at 65uC for 10 min. The protein extract was considered
telomerase-positive if the net increase of absorbance for the sample
DA( A sample2Aheat-treated sample)w a s .0.150.
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Cells were induced in the following adipogenic medium for 2–3
weeks: DMEM supplemented with 10% FBS plus dexamethasone
(1 mM; Sigma), human recombinant insulin (10 mM; Sigma),
indomethacin (200 mM; Fluka, Milan, Italy) and 3-isobutyl-1-
methyl-xantine (IBMX) (0.5 mM; Sigma). Cells cultured in basal
medium (see above) were used as controls.
Angiogenic differentiation using methylcellulose
To analyze in vitro capillary-like morphology,
2610
525610
5 cells/ml were plated in 24-well plates in a
semisolid growth medium that consisted of 0.9% methylcellulose
in DMEM, 30% FBS, 1% bovine serum albumin (BSA),
10
24 mol/L mercaptoethanol, and 2 mmol/L L-glutammine. In
parallel experiments, cultures were stimulated in addition with
vascular endothelial growth factor (VEGF, 50 ng/ml). All cultures
were performed in triplicate, incubated at 37uC under 5% CO2
and left for 7 days to develop a capillary-like morphology.
ELISA assays
In order to quantify VEGF levels produced in the standard
medium from cells CD34
+/CD90
+, we performed VEGF ELISA
assay with an Endogen detection kit (TEMA research, Bologna,
Italy) according to the manufacturer’s protocol. The standard
mediums were collected at 1, 5, 6, 7, 9, 12 days in the first assay
and at 12, 24, 48, 72, 120 and 144 hours from sorting in the
second assay.
Immunofluorescence and Immunohistochemical staining
Cells in P6 well plates were washed in PBS and fixed with 4%
PFA for 30 min at 4uC, then washed three times in PBS for
10 min and incubated in PBS/5%FBS for 60 min at 4uC. After a
double washing in PBS for 10 min at room temperature, cells were
incubated overnight at 4uC with monoclonal anti-human
antibodies (diluted 1:100 in PBS). Wells were washed in PBS
three times for 10 min at room temperature and incubated for
90 min at 4uC with the secondary FITC- or PE-conjugated
antibody (diluted 1:200 in PBS 1X) (Santa Cruz, CA, USA).
Moreover, cells were stained with DAPI (49, 6-diamidino-2-
phenylindole) (Invitrogen, San Giuliano Milanese, Milan, Italy)
diluted 1:10000 (5 mg/ml) in PBS for 7 min at room temperature.
Cells incubated for 90 min at 4uC only with conjugated secondary
antibodies were used as negative control. Cells were then observed
under a fluorescence microscope (Nikon Instruments Italia,
Calenzano, Firenze, Italy). Primary antibodies included: anti-
CD31, anti-CD90 and anti-VEGF, all purchased from Santa
Cruz, CA, USA.
Immunohistochemical analyses were performed with a DAKO
CYTOMATION kit (En Vision + System-HRP-AEC, Dako
Italia, Milan, Italy) according to the manufacturer’s protocol.
Antibodies used were: anti-adiponectin and anti-VEGF, all
purchased from AbCam, Cambridge, UK.
RNA isolation and polymerase chain reaction
RNA was extracted with TRI Reagent (Sigma, Milan, Italy).
cDNA synthesis was lead on total RNA by SuperScript II reverse
transcriptase (Invitrogen, San Giuliano Milanese, Milan, Italy).
Used primers sequences: GADPH: fw AGCCGCATCTTCTTTTG-
CGTC; rw TCATATTTGGCAGGTTTTTCT; CD34: fw AAAGACC-
CTGATTGCACTGG rw GCCCTGAGTCAATTTCACTT; CD90: fw
CCCAGTGAAGATGCAGGTTT; rw GACAGCCTGAGAGGGTCTTG;
CD44: fw TCCAAAGGTTTTCCATCCTG; rw AGGGCCAGCCTC-
TATGAAAT; CD54: fw CAGGTTGTAACACTGCAGGAGAG; rw
ATTGTGAACACTGGCAGAAATG; VEGF: fw TGACAGGGAAGAG-
GAGGAGA; rw CGTCTGACCTGGGGTAGAGA; PPARc: fw ACAG-
CAAACCCCTATTCCATGC; rw: ATTACGGAGAGATCCACGGAGC;
Adiponectin: fw CAACATTCCTGGGCTGTACT; rw CCTGTGAAGG-
TGGAGTCATT.
Statistical analysis
Student t-test (two-tailed) was used for statistical evaluation.
Level of significance was set at p,0.05.
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